Cite

HARVARD Citation

    Yoo, Y. et al. (n.d.). P01.21 Validation of Romo1 inhibitors as the mitochondrial ROS enhancer for anticancer drug development. Journal for immunotherapy of cancer. p. A18. [Online]. 
  
Back to record